A generally immunosuppressive TME characterized by abundant Treg infiltration and the absence of exhausted CD8 T cells for gastric cancer (GC) patients was identified through the scRNA-seq analysis performed by Li Y. et al. (2022), which to some extent accounted for GC patients’ low response rate towards ICI treatment. The gene discussed is CD8A; the disease is gastric cancer.